Delia Goletti
Delia Goletti publishes mostly in Infectious Diseases, Epidemiology and Surgery, on topics such as Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis and Infectious Diseases and Tuberculosis.
- World rank
- #29,991 of 7,710,434 ranked researchers
- Rank in Italy
- #533 of 242,206
- Works
- 467
- Citations
- 30k
- Citations per work
- 63.3
What does Delia Goletti research?
Delia Goletti's work is mostly in Medicine (67%), Immunology and Microbiology (10%), Biochemistry, Genetics and Molecular Biology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences31467.3%
- Medicine31467.3%
- Everything else9119.5%
- Life Sciences6213.2%
- 1Infectious Diseases34% of their works
- 2Epidemiology16% of their works
- 3Surgery14% of their works
- 4Immunology10% of their works
- 5Rheumatology3% of their works
- 6Molecular Biology3% of their works
Research topics
- Tuberculosis Research and Epidemiology
- Mycobacterium research and diagnosis
- Infectious Diseases and Tuberculosis
- Diagnosis and treatment of tuberculosis
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Pneumocystis jirovecii pneumonia detection and treatment
- Pneumonia and Respiratory Infections
Which keywords describe Delia Goletti's research?
The keywords of their largest research topics: Epidemiology, Diagnosis, Treatment, Immune Response, Vaccine, Mycobacterium tuberculosis, Tuberculosis and Antiretroviral Therapy.
- Community-Acquired Pneumonia
- Pneumocystis
- Coronavirus
- Clinical Characteristics
- Abdominal Tuberculosis
- Spinal Epidural Abscess
- Mycobacterium avium
- ACE2 Receptor
- Antiretroviral Therapy
- Mycobacterium tuberculosis
- Immune Response
- Diagnosis
- Epidemiology
- Treatment
- Vaccine
- Tuberculosis
- Clinical Practice Guidelines
- SARS-CoV-2
- Nontuberculous Mycobacteria
- Tuberculous Meningitis
- Diagnostic Challenges
- Thrombosis
- spike protein
- Pneumonia
- Pneumococcal Conjugate Vaccine
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 25 words, with their numbers
- Epidemiology5335 topics
- Diagnosis4443 topics
- Treatment4443 topics
- Immune Response3602 topics
- Vaccine3572 topics
- Mycobacterium tuberculosis3051 topic
- Tuberculosis3051 topic
- Antiretroviral Therapy1382 topics
- Clinical Practice Guidelines1282 topics
- ACE2 Receptor1072 topics
- SARS-CoV-21072 topics
- Mycobacterium avium951 topic
- Nontuberculous Mycobacteria951 topic
- Spinal Epidural Abscess941 topic
- Tuberculous Meningitis941 topic
- Abdominal Tuberculosis831 topic
- Diagnostic Challenges831 topic
- Clinical Characteristics551 topic
- Thrombosis551 topic
- Coronavirus521 topic
- spike protein521 topic
- Pneumocystis441 topic
- Pneumonia441 topic
- Community-Acquired Pneumonia341 topic
- Pneumococcal Conjugate Vaccine341 topic
Where does Delia Goletti work?
Delia Goletti's main affiliation in the publication record is Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, Italy.
How many publications and citations does Delia Goletti have?
OpenAlex counts 467 works and 29,559 citations for Delia Goletti, an h-index of 83, ranking #29,991 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Delia Goletti. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.